NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

549 hedge funds and large institutions have $12.5B invested in Neurocrine Biosciences in 2023 Q4 according to their latest regulatory filings, with 92 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
549
Holders Change
+41
Holders Change %
+8.07%
% of All Funds
8.05%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.18%
New
92
Increased
205
Reduced
197
Closed
43
Calls
$64.4M
Puts
$54.6M
Net Calls
+$9.73M
Net Calls Change
-$6.76M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$613M
2
Dodge & Cox
2
Dodge & Cox
California
$166M
3
PCH
3
Polar Capital Holdings
United Kingdom
$110M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$262M
5
Los Angeles Capital Management
5
Los Angeles Capital Management
California
$121M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$183M
2
Citadel Advisors
2
Citadel Advisors
Florida
$14.8M
3
Millennium Management
3
Millennium Management
New York
$90.8M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$129M
5
FCM
5
Farallon Capital Management
California
$9.54M
Name Holding Trade Value Shares
Change 		Shares
Change %
Franklin Resources
26
Franklin Resources
California
$102M +$807K +6,124 +0.8%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$99.2M +$7.97M +60,491 +9%
AQR Capital Management
28
AQR Capital Management
Connecticut
$97.2M +$48M +364,890 +98%
EAM
29
Eagle Asset Management
Florida
$96M +$142K +1,074 +0.1%
BNP Paribas Asset Management
30
BNP Paribas Asset Management
France
$94.9M +$5.57M +42,263 +6%
B
31
Braidwell
Connecticut
$94.2M -$33.3M -252,815 -26%
Goldman Sachs
32
Goldman Sachs
New York
$91.1M -$12.6M -95,323 -12%
Millennium Management
33
Millennium Management
New York
$90.8M -$76.3M -579,310 -46%
Charles Schwab
34
Charles Schwab
California
$90.5M +$8.38M +63,568 +10%
Invesco
35
Invesco
Georgia
$88.8M +$37.9M +287,693 +75%
APM
36
Avidity Partners Management
Texas
$86.7M +$777K +5,900 +0.9%
UBS AM
37
UBS AM
Illinois
$81.4M +$3.71M +28,162 +5%
Westfield Capital Management
38
Westfield Capital Management
Massachusetts
$78.3M -$7.23M -54,855 -8%
First Trust Advisors
39
First Trust Advisors
Illinois
$77.8M +$16.7M +127,085 +27%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$77.3M -$663K -5,035 -0.9%
GKIM
41
GW&K Investment Management
Massachusetts
$70.6M -$2.48M -18,829 -3%
O
42
OrbiMed
New York
$68.4M +$13.6M +103,379 +25%
Fiera Capital (Canada)
43
Fiera Capital (Canada)
Quebec, Canada
$68.1M +$724K +5,497 +1%
IC
44
IEQ Capital
California
$63.6M +$201K +1,528 +0.3%
Bank of America
45
Bank of America
North Carolina
$62.3M -$11.4M -86,792 -16%
SCM
46
Sarissa Capital Management
Connecticut
$61.9M +$13.7M +104,000 +28%
Jennison Associates
47
Jennison Associates
New York
$59.5M +$5.53M +41,987 +10%
Legal & General Group
48
Legal & General Group
United Kingdom
$58.2M -$875K -6,641 -1%
Ameriprise
49
Ameriprise
Minnesota
$56.1M -$9.6M -72,842 -15%
Principal Financial Group
50
Principal Financial Group
Iowa
$55.1M +$5.31M +40,289 +11%
1
2
3 4 5